| Hepatic Artery Infusion (HAI) Program at Duke University (NCT04511793) | Michael Lidsky, M.D. | 2020-12-11 |
| SGM-101 in Colorectal Lung Metastases (NCT04737213) | Leiden University Medical Center | 2020-11-01 |
| A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer (NCT04322539) | Hutchison Medipharma Limited | 2020-08-12 |
| Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer (NCT03803553) | Massachusetts General Hospital | 2020-04-16 |
| Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial (NCT05468892) | University of Campania Luigi Vanvitelli | 2019-10-29 |
| Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer (NCT03764137) | University of Alabama at Birmingham | 2019-03-14 |
| Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients (NCT03694938) | Poitiers University Hospital | 2019-02-07 |
| Curcumin in Combination With 5FU for Colon Cancer (NCT02724202) | Baylor Research Institute | 2018-02-20 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
| Pembrolizumab + Poly-ICLC in MRP Colon Cancer (NCT02834052) | Asha Nayak | 2018-01-10 |
| A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers (NCT03251378) | Hutchison Medipharma Limited | 2017-12-11 |
| ZETA : Prospective Observational Study (NCT03730558) | Recherche clinique | 2017-11-08 |
| Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers (NCT03073473) | Cota Inc. | 2017-02-28 |
| Development of Clinical and Biological Database in Colorectal Cancer (NCT04186117) | Institut du Cancer de Montpellier - Val d'Aurelle | 2016-09-09 |
| Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients (NCT02655952) | WntResearch AB | 2016-04-01 |
| Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer (NCT02618356) | Fudan University | 2015-12-25 |
| Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors (NCT03176485) | University of Arizona | 2014-10-17 |
| A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients (NCT02291744) | Fudan University | 2014-10-01 |
| Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer (NCT02254941) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2014-08-01 |
| Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors (NCT01936961) | Western Regional Medical Center | 2013-06-01 |
| Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response (NCT01292356) | Poitiers University Hospital | 2010-12-20 |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver (NCT00986661) | Provectus Biopharmaceuticals, Inc. | 2009-10-01 |